cdb-news
A A A

CDB Seminars
All welcome

__

All Seminars are held in the Gavin De Beer Lecture Theatre, Anatomy Building, Thursday 1-2pm (unless otherwise stated)

Thursday 9 July: midday-2.40pm

Host: Yoshiyuki Yamamoto

Room 249, 2nd Floor, Medical Sciences Building, Gower Street

12.00pm  Heather Steele-Stallard: “Human iPS cell-based platforms for disease modelling and therapy screening for laminopathies”
12.15pm  Terry Felton: “Regulation of asymmetric neurogenesis in C. elegans
12.30pm  Marcus Ghosh: “Assigning Behavioural and Neurodevelopmental Functions to Autism-associated Genes”
12.45pm  Giulia Ferrari: “Towards a genomic integration-free, iPS cell and human artificial chromosome-based therapy for Duchenne muscular dystrophy”
1.00pm  Michele Sammut: “Mystery cells in C.elegans: Sex, Glia transdifferation and Learning”
1.15pm  Johanna Buchler: "The Wnt co-receptor LRP6 and synapse regulation".
1.30pm  

Interval
1.40pm  Renato Martinho: “The Asymmetric Habenula of Zebrafish: from Transcriptome to Behaviour”
1.55pm  Alex Fedorec: “Plasmid persistence: balancing plasmid stability and host competitiveness”
2.10pm  Maryam Khosravi: "Investigating novel genetic associations with ciliopathy in the zebrafish"
2.25pm  Marc Williams: “Identification of neutral tumour evolution across cancer types”

See all seminars

Find us on Facebook

CDB Scientists discover genes 'decide who wins body’s battle with cancer'

14 July 2010

A team of scientists led by Dr Yasuyuki Fujita have discovered that two genes, called Mahjong and Lgl, could be star players in helping to identify how the body’s own cells fight back against cancer cells.

Yasuyuki Fujita

This discovery could lead to future treatments to make healthy cells better-equipped to attack cancer cells, an entirely new concept for cancer research.

The team, funded by the Medical Research Council (MRC) and based at the MRC Laboratory for Molecular Cell Biology (LMCB) Unit at UCL, have proven that normal cells and cancerous cells compete in a game of ‘do or die’.

If the non-cancerous cells gain the advantage and entirely surround the cancer cells, the cancer cells will die.

If, however, the cancerous cells manage to break free, they will continue to divide and grow undisturbed.Dr Fujita holds a joint affiliation with CDB and the MRC LMCB.

Links:

View all CDB News

Page last modified on 20 may 10 14:52 by Glenda Young